Matches in Wikidata for { <http://www.wikidata.org/entity/Q64817061> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64817061 description "clinical trial" @default.
- Q64817061 description "ensayu clínicu" @default.
- Q64817061 description "klinisch onderzoek" @default.
- Q64817061 description "клінічне випробування" @default.
- Q64817061 name "A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer" @default.
- Q64817061 type Item @default.
- Q64817061 label "A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer" @default.
- Q64817061 prefLabel "A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer" @default.
- Q64817061 P1132 Q64817061-A319D897-E2E1-4720-83B0-25A93FCFD5AD @default.
- Q64817061 P1476 Q64817061-C282C20A-72D6-45B4-847D-D6D3B72C7B04 @default.
- Q64817061 P17 Q64817061-19EDE8BC-49AE-49D5-829F-9B4C0CBC05ED @default.
- Q64817061 P17 Q64817061-5F30F482-9A39-4F3D-B186-80540D652E60 @default.
- Q64817061 P17 Q64817061-662C62F1-9BAD-472D-9D3E-BE7CB4CC3B56 @default.
- Q64817061 P17 Q64817061-959A7B4A-B092-49F8-B1F4-F895543B56AE @default.
- Q64817061 P17 Q64817061-B89128BC-9E45-4312-864D-1AEC5C30E069 @default.
- Q64817061 P2899 Q64817061-3F4E7924-4166-4150-9D7F-2AF9F3F9B7F8 @default.
- Q64817061 P3098 Q64817061-3683D2CD-2542-4C60-9A97-804D93184892 @default.
- Q64817061 P31 Q64817061-996F1E1F-F6B2-4FA6-B037-3FC5131E879C @default.
- Q64817061 P580 Q64817061-B3C76B15-C3D4-4A03-9B65-F6C78930E74F @default.
- Q64817061 P582 Q64817061-581F180A-8F4E-472F-A648-5AC65BB62C85 @default.
- Q64817061 P6099 Q64817061-0806E107-6F42-464A-8F58-964A081F4459 @default.
- Q64817061 P6153 Q64817061-0D5952E0-C2F7-4C25-8965-57FBAAA90801 @default.
- Q64817061 P6153 Q64817061-52111918-E46F-410E-AED2-7E663D33331E @default.
- Q64817061 P6153 Q64817061-BFAE965B-5CEF-44A7-B408-6A8B35DABA60 @default.
- Q64817061 P8363 Q64817061-062CAFA0-782B-4958-B7A1-3DF294683BC1 @default.
- Q64817061 P859 Q64817061-C03A6B61-357C-4017-B73D-B1B871FCFFCD @default.
- Q64817061 P1132 "+116" @default.
- Q64817061 P1476 "Open Label, Dose Finding and Expansion Phase IB Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (Pd L1 Antibody) in Pateints With Advanced Ovarian Cancer or Triple Negative Breast Cancer" @default.
- Q64817061 P17 Q145 @default.
- Q64817061 P17 Q16 @default.
- Q64817061 P17 Q30 @default.
- Q64817061 P17 Q35 @default.
- Q64817061 P17 Q408 @default.
- Q64817061 P2899 "+18" @default.
- Q64817061 P3098 "NCT03292172" @default.
- Q64817061 P31 Q30612 @default.
- Q64817061 P580 "2017-11-08T00:00:00Z" @default.
- Q64817061 P582 "2021-01-16T00:00:00Z" @default.
- Q64817061 P6099 Q5452194 @default.
- Q64817061 P6153 Q1159198 @default.
- Q64817061 P6153 Q5118186 @default.
- Q64817061 P6153 Q640652 @default.
- Q64817061 P8363 Q78089383 @default.
- Q64817061 P859 Q212646 @default.